A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

2001/10/01 by L.M. Refolo, Lorenzo M. Refolo, Miguel A. Pappolla +18 · 2 citations
Medicine · Neuroscience · #Alzheimer's disease research and treatments #Cholesterol and Lipid Metabolism #Nuclear Receptors and Signaling

paper · doi:10.1006/nbdi.2001.0422

openalex publication_date 2001/10/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/08/01

Cited by

• Iron Behaving Badly: Inappropriate Iron Chelation as a Major Contributor to the Aetiology of Vascular and Other Progressive Inflammatory and Degenerative Diseases
• Oleuropein in Olive and its Pharmacological Effects